These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9002007)

  • 21. Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials.
    Felson DT
    J Rheumatol; 1993 Mar; 20(3):531-4. PubMed ID: 8478865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Thompson articular index.
    van den Brink HR; van der Heide A; Jacobs JW; van der Veen MJ; Bijlsma JW
    J Rheumatol; 1993 Jan; 20(1):28-32. PubMed ID: 8441161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis.
    Husted J; Gladman DD; Long JA; Farewell VT
    J Rheumatol; 1996 Nov; 23(11):1932-7. PubMed ID: 8923369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
    Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires.
    Pincus T
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):32-9. PubMed ID: 17121487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis?
    van der Helm-van Mil AH; Knevel R; van der Heijde D; Huizinga TW
    Rheumatology (Oxford); 2010 Aug; 49(8):1429-35. PubMed ID: 20202925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis.
    Orces CH; Del Rincón I; Abel MP; Escalante A
    Arthritis Rheum; 2002 Feb; 47(1):67-72. PubMed ID: 11932880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting individual differences in pain and functional impairment among patients with rheumatoid arthritis.
    Hagglund KJ; Haley WE; Reveille JD; Alarcón GS
    Arthritis Rheum; 1989 Jul; 32(7):851-8. PubMed ID: 2751719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis.
    Kim WU; Kim KJ
    J Rheumatol; 2005 Feb; 32(2):225-30. PubMed ID: 15693081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of oxidative stress in rheumatoid arthritis.
    Vasanthi P; Nalini G; Rajasekhar G
    Int J Rheum Dis; 2009 Apr; 12(1):29-33. PubMed ID: 20374313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory markers of disease activity.
    Richardson C; Emery P
    J Rheumatol Suppl; 1996 Mar; 44():23-30. PubMed ID: 8833047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a disease activity score based on judgment in clinical practice by rheumatologists.
    van der Heijde DM; van 't Hof M; van Riel PL; van de Putte LB
    J Rheumatol; 1993 Mar; 20(3):579-81. PubMed ID: 8478878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression.
    Wolfe F; Sharp JT
    Arthritis Rheum; 1998 Sep; 41(9):1571-82. PubMed ID: 9751089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiographic remission in seropositive rheumatoid arthritis. A 20-year follow-up study.
    Jäntti J; Kaarela K; Kautiainen H; Isomäki H; Aho K
    Clin Exp Rheumatol; 2001; 19(5):573-6. PubMed ID: 11579719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of multiple synovectomy for patients with refractory rheumatoid arthritis. Effects on disease activity and radiological progression.
    Nakamura H; Tanaka H; Yoshino S
    Clin Exp Rheumatol; 2004; 22(2):151-7. PubMed ID: 15083881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis.
    Furst DE
    Rheum Dis Clin North Am; 1994 May; 20(2):309-19. PubMed ID: 8016413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes in rheumatoid arthritis.
    Pincus T
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():59-73. PubMed ID: 8535651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiologically observed progression of joint destruction and its relationship with demographic factors, disease severity, and exercise frequency in patients with rheumatoid arthritis.
    Stenström CH
    Phys Ther; 1994 Jan; 74(1):32-9. PubMed ID: 8265726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of established rheumatoid arthritis.
    van Gestel AM; Stucki G
    Baillieres Best Pract Res Clin Rheumatol; 1999 Dec; 13(4):629-44. PubMed ID: 10652644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grading of tenderness as a source of interrater error in the Ritchie articular index.
    Hart LE; Tugwell P; Buchanan WW; Norman GR; Grace EM; Southwell D
    J Rheumatol; 1985 Aug; 12(4):716-7. PubMed ID: 4057194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.